Number of trials per comparison | |
typical loopa | NO = 1, NP = 3, OP = 4 |
double | NO = 2, NP = 6, OP = 8 |
Trial size | |
placebo-controlled trials | Unif(102, 187) |
old-controlled trials | Unif(128, 241) |
Initial event rates of control arm | |
placebo-controlled trials | Unif(0.27, 0.40) |
old-controlled trials | Unif(0.63, 0.76) |
Balanced risk of missing outcome data | |
low | Unif(0, 0.04) |
moderate | Unif(0.05, 0.20) |
large | Unif(0.21, 0.40) |
Unbalanced risk of missing outcome data | |
low | Unif(0, 0.04)b |
moderate | Unif(0.05, 0.10) for E, Unif(0.11, 0.20) for C |
large | Unif(0.21, 0.30) for E, Unif(0.31, 0.40) for C |
Missingness mechanisms via log (IMOR) | |
informative | TN(μ = − ln (2), σ2 = 1, a = ln (1)) for Placebo |
TN(μ = ln (2), σ2 = 1, a = ln (1)) for New and Old | |
missing at random | N(0, 1) for all interventions |
Treatment effects | |
basic comparisons | LORNP = ln (2), LOROP = ln (1.5) |
functional comparison | LORNO = LORNP − LOROP + IF |
Loop inconsistency | |
inconsistency factor (IF)c | IF = absent IF = moderate |
Common between-trial variance | |
predictive distributiond | τ2 = 0.02 (small) τ2 = 0.08 (substantial) |
Surface under cumulative ranking curve | |
new intervention | 96 and 88% for small and substantial τ2, respectively |
old intervention | 54 and 58% for small and substantial τ2, respectively |
placebo | 0 and 4% for small and substantial τ2, respectively |